CPLM 1.0 - Compendium of Protein Lysine Modification
TagContent
CPLM ID CPLM-015887
UniProt Accession
Genbank Protein ID
Genbank Nucleotide ID
Protein Name
 Zinc finger CCCH-type antiviral protein 1 
Protein Synonyms/Alias
 ADP-ribosyltransferase diphtheria toxin-like 13; ARTD13; Zinc finger CCCH domain-containing protein 2; Zinc finger antiviral protein; ZAP 
Gene Name
 ZC3HAV1 
Gene Synonyms/Alias
 ZC3HDC2; PRO1677 
Created Date
 July 27, 2013 
Organism
 Homo sapiens (Human) 
NCBI Taxa ID
 9606 
Lysine Modification
Position
Peptide
Type
References
783SQMKEEGKLLFYATSubiquitination[1, 2]
Reference
 [1] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.
 Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C.
 Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [PMID: 21890473]
 [2] Proteome-wide identification of ubiquitylation sites by conjugation of engineered lysine-less ubiquitin.
 Oshikawa K, Matsumoto M, Oyamada K, Nakayama KI.
 J Proteome Res. 2012 Feb 3;11(2):796-807. [PMID: 22053931
Functional Description
 Antiviral protein which inhibits the replication of viruses by recruiting the cellular RNA degradation machineries to degrade the viral mRNAs. Binds to a ZAP-responsive element (ZRE) present in the target viral mRNA, recruits cellular poly(A)- specific ribonuclease PARN to remove the poly(A) tail, and the 3'- 5' exoribonuclease complex exosome to degrade the RNA body from the 3'-end. It also recruits the decapping complex DCP1-DCP2 through RNA helicase p72 (DDX17) to remove the cap structure of the viral mRNA to initiate its degradation from the 5'-end. Its target viruses belong to families which include retroviridae: human immunodeficiency virus type 1 (HIV-1), moloney and murine leukemia virus (MoMLV) and xenotropic MuLV-related virus (XMRV), filoviridae: ebola virus (EBOV) and marburg virus (MARV), togaviridae: sindbis virus (SINV) and Ross river virus (RRV). Specifically targets the multiply spliced but not unspliced or singly spliced HIV-1 mRNAs for degradation. Isoform 1 is a more potent viral inhibitor than isoform 2. Isoform 2 acts as a positive regulator of DDX58/RIG-I signaling resulting in activation of the downstream effector IRF3 leading to the expression of type I IFNs and IFN stimulated genes (ISGs). 
Sequence Annotation
 DOMAIN 594 681 WWE.
 DOMAIN 716 902 PARP catalytic.
 ZN_FING 73 86 C3H1-type 1.
 ZN_FING 88 110 C3H1-type 2.
 ZN_FING 150 172 C3H1-type 3.
 ZN_FING 169 193 C3H1-type 4.
 REGION 2 254 N-terminal domain.
 REGION 224 254 Binding to EXOSC5 (By similarity).
 MOTIF 69 76 Nuclear localization signal (By
 MOTIF 285 292 Nuclear export signal (By similarity).
 MOD_RES 2 2 N-acetylalanine.
 MOD_RES 257 257 Phosphoserine; by GSK3-beta.
 MOD_RES 263 263 Phosphoserine; by GSK3-beta (By
 MOD_RES 267 267 Phosphoserine; by GSK3-beta (By
 MOD_RES 271 271 Phosphoserine; by GSK3-beta.
 MOD_RES 273 273 Phosphothreonine.
 MOD_RES 275 275 Phosphoserine.
 MOD_RES 284 284 Phosphoserine.
 MOD_RES 302 302 Phosphoserine.
 MOD_RES 327 327 Phosphoserine (By similarity).
 MOD_RES 335 335 Phosphoserine.
 MOD_RES 355 355 Phosphoserine (By similarity).
 MOD_RES 378 378 Phosphoserine.
 MOD_RES 387 387 Phosphoserine.
 MOD_RES 393 393 Phosphothreonine.
 MOD_RES 492 492 Phosphoserine.  
Keyword
 3D-structure; Acetylation; Alternative splicing; Antiviral defense; Complete proteome; Cytoplasm; Immunity; Innate immunity; Metal-binding; Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Repeat; RNA-binding; Zinc; Zinc-finger. 
Sequence Source
 UniProt (SWISSPROT/TrEMBL); GenBank; EMBL 
Protein Length
 902 AA 
Protein Sequence
MADPEVCCFI TKILCAHGGR MALDALLQEI ALSEPQLCEV LQVAGPDRFV VLETGGEAGI 60
TRSVVATTRA RVCRRKYCQR PCDNLHLCKL NLLGRCNYSQ SERNLCKYSH EVLSEENFKV 120
LKNHELSGLN KEELAVLLLQ SDPFFMPEIC KSYKGEGRQQ ICNQQPPCSR LHICDHFTRG 180
NCRFPNCLRS HNLMDRKVLA IMREHGLNPD VVQNIQDICN SKHMQKNPPG PRAPSSHRRN 240
MAYRARSKSR DRFFQGSQEF LASASASAER SCTPSPDQIS HRASLEDAPV DDLTRKFTYL 300
GSQDRARPPS GSSKATDLGG TSQAGTSQRF LENGSQEDLL HGNPGSTYLA SNSTSAPNWK 360
SLTSWTNDQG ARRKTVFSPT LPAARSSLGS LQTPEAVTTR KGTGLLSSDY RIINGKSGTQ 420
DIQPGPLFNN NADGVATDIT STRSLNYKST SSGHREISSP RIQDAGPASR DVQATGRIAD 480
DADPRVALVN DSLSDVTSTT SSRVDDHDSE EICLDHLCKG CPLNGSCSKV HFHLPYRWQM 540
LIGKTWTDFE HMETIEKGYC NPGIHLCSVG SYTINFRVMS CDSFPIRRLS TPSSVTKPAN 600
SVFTTKWIWY WKNESGTWIQ YGEEKDKRKN SNVDSSYLES LYQSCPRGVV PFQAGSRNYE 660
LSFQGMIQTN IASKTQKDVI RRPTFVPQWY VQQMKRGPDH QPAKTSSVSL TATFRPQEDF 720
CFLSSKKYKL SEIHHLHPEY VRVSEHFKAS MKNFKIEKIK KIENSELLDK FTWKKSQMKE 780
EGKLLFYATS RAYVESICSN NFDSFLHETH ENKYGKGIYF AKDAIYSHKN CPYDAKNVVM 840
FVAQVLVGKF TEGNITYTSP PPQFDSCVDT RSNPSVFVIF QKDQVYPQYV IEYTEDKACV 900
IS 902 
Gene Ontology
 GO:0005737; C:cytoplasm; IDA:UniProtKB.
 GO:0005794; C:Golgi apparatus; IDA:HPA.
 GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
 GO:0005886; C:plasma membrane; IDA:HPA.
 GO:0003950; F:NAD+ ADP-ribosyltransferase activity; IEA:InterPro.
 GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
 GO:0008270; F:zinc ion binding; IEA:InterPro.
 GO:0071360; P:cellular response to exogenous dsRNA; IEA:Compara.
 GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
 GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
 GO:0045071; P:negative regulation of viral genome replication; IDA:UniProtKB.
 GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB cascade; IMP:UniProtKB.
 GO:0032727; P:positive regulation of interferon-alpha production; IDA:UniProtKB.
 GO:0032728; P:positive regulation of interferon-beta production; IDA:UniProtKB.
 GO:0061014; P:positive regulation of mRNA catabolic process; IDA:UniProtKB.
 GO:1900246; P:positive regulation of RIG-I signaling pathway; IMP:UniProtKB.
 GO:0032481; P:positive regulation of type I interferon production; IEA:Compara.
 GO:0009615; P:response to virus; IDA:UniProtKB. 
Interpro
 IPR012317; Poly(ADP-ribose)pol_cat_dom.
 IPR004170; WWE-dom.
 IPR000571; Znf_CCCH. 
Pfam
 PF00644; PARP 
SMART
  
PROSITE
 PS51059; PARP_CATALYTIC
 PS50918; WWE
 PS50103; ZF_C3H1 
PRINTS